- Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
-
Choi R, Jeong BH, Koh WJ, Lee SY
- KMID: 2373626
- Ann Lab Med.
- 2017 Mar;37(2):97-107.
- doi: 10.3343/alm.2017.37.2.97
Although tuberculosis is largely a curable disease, it remains a major cause of morbidity and mortality worldwide. Although the standard 6-month treatment regimen is highly effective for drug-susceptible tuberculosis, the... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Paradoxical Reaction Development during Antituberculosis Therapy
-
Cho YB, Chu MS, Ryu HS, Choi SC, Seo GS
- KMID: 2373227
- Korean J Gastroenterol.
- 2015 May;65(5):306-311.
- doi: 10.4166/kjg.2015.65.5.306
Paradoxical reaction during antituberculosis therapy is defined as aggravation of preexisting tuberculous lesions or the development of new lesions. A 24-year-old female college student diagnosed with abdominal and pulmonary tuberculosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
-
Lee J, Lee CH, Kim DK, Yoon HI, Kim JY, Lee SM, Yang SC, Lee JH, Yoo CG, Lee CT, Chung HS, Kim YW, Han SK, Yim JJ
- KMID: 1776587
- Korean J Intern Med.
- 2011 Jun;26(2):153-159.
- doi: 10.3904/kjim.2011.26.2.153
BACKGROUND/AIMS: To compare the effect of levofloxacin and moxifloxacin on treatment outcomes among patients with multidrug-resistant tuberculosis (MDR-TB). METHODS: A retrospective analysis of 171 patients with MDR-TB receiving either levofloxacin or... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Response and Adverse Reactions in Older Tuberculosis Patients with Immunocompromising Comorbidities
-
Kim SY, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Yang SC
- KMID: 1793172
- Yonsei Med J.
- 2013 Sep;54(5):1227-1233.
- doi: 10.3349/ymj.2013.54.5.1227
PURPOSE: The aim of this study was to elucidate the effects of immunocompromising comorbidities on treatment response and adverse reactions in older tuberculosis (TB) patients. MATERIALS AND METHODS: The medical records... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Tuberculosis in Renal Transplant Recipients
-
Park YS, Choi JY, Cho CH, Chang KH, Song YG, Kim YS, Kim JM
- KMID: 1103909
- Yonsei Med J.
- 2004 Oct;45(5):865-872.
- doi: 10.3349/ymj.2004.45.5.865
Tuberculosis (TB) is an important cause of morbidity and mortality in renal transplant recipients. Rifampin has a potent sterilizing activity, but it reduces the serum concentrations of the immunosuppressive agents.... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication
-
Lee YM, Huh KC, Yoon SM, Jang BI, Shin JE, Koo HS, Jung Y, Kim SH, Moon HS, Lee SW, Daejeon-Chungchung Intestinal Research Group
- KMID: 2363970
- Gut Liver.
- 2016 Mar;10(2):250-254.
- doi: 10.5009/gnl14435
BACKGROUND/AIMS: To determine the incidence and clinical characteristics of tuberculosis (TB) medication-associated Clostridium difficile infection. METHODS: This multicenter study included patients from eight tertiary hospitals enrolled from 2008 to 2013. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of Default from Treatment for Tuberculosis: a Single Center Case-Control Study in Korea
-
Park CK, Shin HJ, Kim YI, Lim SC, Yoon JS, Kim YS, Kim JC, Kwon YS
- KMID: 2360050
- J Korean Med Sci.
- 2016 Feb;31(2):254-260.
- doi: 10.3346/jkms.2016.31.2.254
Default from tuberculosis (TB) treatment could exacerbate the disease and result in the emergence of drug resistance. This study identified the risk factors for default from TB treatment in Korea.... -
- CITED
-
- Close
- SHARE
-
- Close
